Considering that MPS1 and HDAC8 are closely associated with the formation of chromosomal structures and both are overexpressed in HCC tumors, dual inhibition of MPS1 and HDAC8 may provide a novel strategy for the treatment of HCC. The gene discussed is HDAC8; the disease is hepatocellular carcinoma.